Cargando…
The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
BACKGROUND: Cervical screening is transitioning from primary cytology to primary human papillomavirus (HPV) testing. HPV testing is highly sensitive but there is currently no high-specificity triage method for colposcopy referral to detect cervical intraepithelial neoplasia grade 3 or above (CIN3+)...
Autores principales: | Barrett, James E., Sundström, Karin, Jones, Allison, Evans, Iona, Wang, Jiangrong, Herzog, Chiara, Dillner, Joakim, Widschwendter, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580141/ https://www.ncbi.nlm.nih.gov/pubmed/36258199 http://dx.doi.org/10.1186/s13073-022-01116-9 |
Ejemplares similares
-
DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test
por: Herzog, Chiara, et al.
Publicado: (2022) -
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples
por: Barrett, James E., et al.
Publicado: (2022) -
The WID‐qEC test: Performance in a hospital‐based cohort and feasibility to detect endometrial and cervical cancers
por: Schreiberhuber, Lena, et al.
Publicado: (2022) -
Methylation in Predicting Progression of Untreated High-grade Cervical Intraepithelial Neoplasia
por: Louvanto, Karolina, et al.
Publicado: (2020) -
Low-Grade Cervical Intraepithelial Neoplasia (CIN1) Evolution: Analysis of Opportunistic Preventive Vaccination Role
por: Gardella, Barbara, et al.
Publicado: (2023)